Takeda Pharmaceutical Company Limited Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities
Takeda Pharmaceutical Company Limited (TKPHF) reported Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities of -JPY 74.74 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities · last filed 2025-06-25
| Period end | Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2025-03-31 | -74.74B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 455.34B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 301.72B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 291.49B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 151.75B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | -135.94B JPY 20-F · filed 2020-06-24 |
| 2019-03-31 | -6.33B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 11.98B JPY 20-F · filed 2019-06-27 |